Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVIY.L Share News (VIY)

  • There is currently no data for VIY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Vialogy eyes global markets

Fri, 31st Dec 2010 09:45

Vialogy, which provides sensor technology used in the oil and gas industry, posted a bigger loss in the six months to 30 September, as the company took a £1.59m hit for amortisation and depreciation.Pre-tax losses grew to £3.37m from £2.80m over the same period the previous year as revenues rose to £57,031 from £11,266. The amortisation charges relate to the value of ViaLogy's intellectual property and associated research and development, which is amortised over a period of six years. The cash outflow from operations during the period was £1.84m.Vialogy said that, while it remains active in Texas, it also made progress in its strategy of penetrating global markets, with five global oil companies requesting presentations on the use of Vialogy's technology in the past 18 months. "At the time of writing, two of these household names are in discussions with us to use the technology in specific major projects," the company said. "We are confident that more business of this calibre will follow."Chief executive Robert Dean said: "Our current sales pipeline indicates that we are in a position to achieve a considerable growth on 2011 and we owe it to our technology and our investors to maximise this potential."
More News
28 Sep 2009 08:18

Vialogy gets Texan boost

Vialogy, the US-based company that develops Internet Protocol (IP) based sensor networks, saw revenue soar last year as its technology moved towards full commercialisation. Revenue in the year to 31 March 2009 rose to £0.13m from £0.03m the year before. Loss before tax widened to £6.2m from £5.3m

Read more
15 Jul 2009 08:44

Small caps round-up: Abcam, Rugby Estates, O Twelve...

Abcam, a biosciences firm that markets antibodies online, said sales for the year have ended slightly ahead of its earlier expectations. Trading in the second half of the year has been strong and the exchange rate environment has been more favourable than was previously envisaged due to the continu

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.